Seth Van Voorhees
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Seth Van Voorhees
Earlier roles on record: CFO at NRX Pharmaceuticals, Inc. (NRXP) until September 30, 2023. NRX Pharmaceuticals, Inc. reported in an 8-K filed September 14, 2023 that Seth Van Voorhees resigned as Chief Financial Officer, effective September 30, 2023. Seth Van Voorhees has spoken on 5 earnings calls across 1 company, most recently for NRX Pharmaceuticals, Inc. on June 30, 2023.
“On September 11, 2023, Seth Van Voorhees, Ph.D., resigned from his position as the Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-09-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.